Novavax Covid-19 vaccine shipments held up by regulatory processes

Novavax, the maker of the Covid-19 vaccine most recently approved by the UK’s medicines regulator, has reportedly delivered a small fraction of the two billion doses it has promised this year. The US biotech firm has delayed its first-quarter shipments in Europe and lower income countries such as the Philippines, Reuters first reported, citing public [...]